# Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-25-040
- **Status:** posted
- **Opens:** November 18, 2024
- **Closes:** September 7, 2026
- **CFDA:** 93.242
- **View on Kontrakk:** https://kontrakk.com/grants/357183

## Description

No description provided.